The Bureau européen des unions de consommateurs (BEUC) is the umbrella organisation that represents the European consumer organisations in Brussels and has done so since its foundation in 1962. It lobbies with the EU institutions to defend the interests of European consumers. In this paper I reconstruct the evolution of BEUC during the first two decades of its existence, from a small and loosely organised alliance of European consumer organisations to a well-established organisation with its own office in Brussels and a clear impact on EEC policy.
Based on archival research, I recount the early history of BEUC by dividing it into five stages of development: birth and infancy (1962-68), childhood (1969-73), adolescence (1974-77), early adulthood (1978-82) and adulthood (1983-85 and beyond). For each phase I discuss the organisational developments within BEUC, the development of its activities and interactions with EEC institutions.
{"title":"The Early Years of the European Consumer Organisation BEUC, 1962-1985","authors":"K. Docter","doi":"10.2139/ssrn.3357791","DOIUrl":"https://doi.org/10.2139/ssrn.3357791","url":null,"abstract":"The Bureau européen des unions de consommateurs (BEUC) is the umbrella organisation that represents the European consumer organisations in Brussels and has done so since its foundation in 1962. It lobbies with the EU institutions to defend the interests of European consumers. In this paper I reconstruct the evolution of BEUC during the first two decades of its existence, from a small and loosely organised alliance of European consumer organisations to a well-established organisation with its own office in Brussels and a clear impact on EEC policy.<br><br>Based on archival research, I recount the early history of BEUC by dividing it into five stages of development: birth and infancy (1962-68), childhood (1969-73), adolescence (1974-77), early adulthood (1978-82) and adulthood (1983-85 and beyond). For each phase I discuss the organisational developments within BEUC, the development of its activities and interactions with EEC institutions.","PeriodicalId":148976,"journal":{"name":"LSN: History of Consumer Law (Sub-Topic)","volume":"470 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130444315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This Article traces the still-evolving view of consumers of FDA-regulated products as capable, rational, and rights-bearing decision makers. It also examines the corresponding diminution of FDA’s role as a paternalistic gatekeeper collaborating with medical and scientific experts to prevent products and manufacturer-provided information from reaching the public. Compared with their 1960s counterparts, today’s consumers of food and drugs have far greater freedom to make unmediated choices among a wider variety of products, guided by a relative deluge of labeling and advertising information. Moreover, food and drug regulation, once the exclusive domain of bureaucrats and experts, has become a focus of successful social movement activism.The Article explores these phenomena against a background of three societal and cultural trends during the past five decades: Americans’ declining trust in major institutions, the “rights revolution,” and the dramatic expansion of health care information accessible to consumers. It then analyzes a variety of specific regulatory developments during this period of change. In its discussion of food, the paper considers the evolution of standards of identity and nutrition labeling, the rise of health claims as facilitated by the First Amendment, and various popular movements for freedom of choice with respect to food ingredients and dietary supplements. The Article then turns to drug regulation, examining the rise of patient labeling and direct-to-consumer advertising of prescription drugs, the tidal wave of “switches” from prescription to over-the-counter status, and the development of social movements intended to shape FDA drug approval policy. The Article concludes by speculating on whether this new model of consumer is a permanent one and by considering the implications of this question for FDA regulation in the future.
{"title":"FDA and the Rise of the Empowered Consumer","authors":"","doi":"10.2139/SSRN.2271141","DOIUrl":"https://doi.org/10.2139/SSRN.2271141","url":null,"abstract":"This Article traces the still-evolving view of consumers of FDA-regulated products as capable, rational, and rights-bearing decision makers. It also examines the corresponding diminution of FDA’s role as a paternalistic gatekeeper collaborating with medical and scientific experts to prevent products and manufacturer-provided information from reaching the public. Compared with their 1960s counterparts, today’s consumers of food and drugs have far greater freedom to make unmediated choices among a wider variety of products, guided by a relative deluge of labeling and advertising information. Moreover, food and drug regulation, once the exclusive domain of bureaucrats and experts, has become a focus of successful social movement activism.The Article explores these phenomena against a background of three societal and cultural trends during the past five decades: Americans’ declining trust in major institutions, the “rights revolution,” and the dramatic expansion of health care information accessible to consumers. It then analyzes a variety of specific regulatory developments during this period of change. In its discussion of food, the paper considers the evolution of standards of identity and nutrition labeling, the rise of health claims as facilitated by the First Amendment, and various popular movements for freedom of choice with respect to food ingredients and dietary supplements. The Article then turns to drug regulation, examining the rise of patient labeling and direct-to-consumer advertising of prescription drugs, the tidal wave of “switches” from prescription to over-the-counter status, and the development of social movements intended to shape FDA drug approval policy. The Article concludes by speculating on whether this new model of consumer is a permanent one and by considering the implications of this question for FDA regulation in the future.","PeriodicalId":148976,"journal":{"name":"LSN: History of Consumer Law (Sub-Topic)","volume":"80 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125533302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号